Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer

Journal of Surgical Oncology

Volumn 105, Issue 7, 2012, Pages 714-718

  Keereweer, Stijn ^a   Mol, Isabel M ^b   Kerrebijn, Jeroen D F ^a   Van Driel, Pieter B A A ^b   Xie, Bangwen ^b   Baatenburg De Jong, Robert J ^a   Vahrmeijer, Alexander L ^b   Löwik, Clemens W G M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

EPR effect; image guided surgery; integrins; optical imaging; oral cancer

Indexed keywords

BETA3 INTEGRIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER CELL; CANCER DIAGNOSIS; CONTROLLED STUDY; EX VIVO STUDY; FEASIBILITY STUDY; FLUORESCENCE IMAGING; HISTOLOGY; HUMAN; HUMAN CELL; INOCULATION; MOLECULAR DYNAMICS; MOUSE; MOUTH CARCINOMA; NEAR INFRARED FLUORESCENCE OPTICAL IMAGING; NONHUMAN; OPTICS; OUTCOME ASSESSMENT; PERMEABILITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; PROTEIN TRANSPORT; SQUAMOUS CELL CARCINOMA; TONGUE; TUMOR GROWTH;

ANIMALS; CARCINOMA, SQUAMOUS CELL; FLUORESCENT DYES; HUMANS; INTEGRIN ALPHAVBETA3; MICE; MICE, INBRED BALB C; MOUTH NEOPLASMS; SPECTROSCOPY, NEAR-INFRARED; SURGERY, COMPUTER-ASSISTED;

EID: 84859900399     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22102     Document Type: Article

References (23)

1. Slootweg PJ, Hordijk GJ, Schade Y, et al.: Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol 2002; 38: 500-503. (Pubitemid 34756736)
2. Binahmed A, Nason RW, Abdoh AA,: The clinical significance of the positive surgical margin in oral cancer. Oral Oncol 2007; 43: 780-784. (Pubitemid 47259444)
3. McMahon J, O'Brien CJ, Pathak I, et al.: Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg 2003; 41: 224-231. (Pubitemid 37184459)
4. Frangioni JV,: New technologies for human cancer imaging. J Clin Oncol 2008; 26: 4012-4021.
5. Keereweer S, Kerrebijn JD, van Driel PB, et al.: Optical Image-guided surgery-Where do we stand? Mol Imaging Biol 2010; 13: 199-207.
6. Hood JD, Cheresh DA,: Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91-100. (Pubitemid 37328796)
7. Fang J, Nakamura H, Maeda H,: The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011; 63: 136-151.
8. Dijkgraaf I, Beer AJ, Wester HJ,: Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. Front Biosci 2009; 14: 887-899.
9. Haubner R, Wester HJ, Weber WA, et al.: Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001; 61: 1781-1785. (Pubitemid 32691983)
10. Desgrosellier JS, Cheresh DA,: Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10: 9-22.
11. Reardon DA, Fink KL, Mikkelsen T, et al.: Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. J Clin Oncol 2008; 26: 5610-5617.
12. Jain RK, Stylianopoulos T,: Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010; 7: 653-664.
13. Torchilin V,: Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 2011; 63: 131-135.
14. Kim JB, Urban K, Cochran E, et al.: Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 2010; 5: e9364.
15. Kossodo S, Pickarski M, Lin SA, et al.: Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT). Mol Imaging Biol 2010; 12: 488-499.
16. Sano D, Choi S, Milas ZL, et al.: The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: A study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg 2009; 135: 411-420.
17. Keereweer S, Sterenborg HJ, Kerrebijn JD, et al.: Image-guided surgery in head and neck cancer: Current practice and future directions of optical imaging. Head Neck 2011; DOI: 10.1002/hed.21625. [Epub ahead of print].
18. Thurber GM, Figueiredo JL, Weissleder R,: Detection limits of intraoperative near infrared imaging for tumor resection. J Surg Oncol 2010; 102: 758-764.
19. Hutteman M, Mieog JS, van der Vorst JR, et al.: Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin alpha(v)beta(3) expression in a syngeneic rat model. Eur J Surg Oncol 2011; 37: 252-257.
20. Gilcrease MZ,: Integrin signaling in epithelial cells. Cancer Lett 2007; 247: 1-25. (Pubitemid 44959416)
21. Jones J, Watt FM, Speight PM,: Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J Oral Pathol Med 1997; 26: 63-68. (Pubitemid 27157727)
22. Sandanaraj BS, Gremlich HU, Kneuer R, et al.: Fluorescent nanoprobes as a biomarker for increased vascular permeability: Implications in diagnosis and treatment of cancer and inflammation. Bioconjug Chem 2010; 21: 93-101.
23. Maeda H,: Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects. Bioconjug Chem 2010; 21: 797-802.